We are live on
!
Find out more
PIM
Partner Investment Management Portfolio holdings
AUM
$13.9M
1-Year Est. Return
55.92%
This Fund
S&P 500
This Quarter
Est. Return
+12.7%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$66.4M
AUM Growth
-$179M
(-73%)
Cap. Flow
-$190M
Cap. Flow
% of AUM
-286.78%
Top 10 Holdings %
Top 10 Hldgs %
30.27%
Holding
112
New
25
Increased
15
Reduced
41
Closed
30
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$1.69M |
| 2 |
AerCap
AER
|
+$1.35M |
| 3 |
Pfizer
PFE
|
+$1.33M |
| 4 |
Illumina
ILMN
|
+$960K |
| 5 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$934K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vulcan Materials
VMC
|
+$21.4M |
| 2 |
Microsoft
MSFT
|
+$18.6M |
| 3 |
Bausch Health
BHC
|
+$10.7M |
| 4 |
MIC
Macquarie Infrastructure Holdings, LLC
MIC
|
+$7.46M |
| 5 |
AGN
Allergan Inc
AGN
|
+$7.37M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 51.77% |
| 2 | Industrials | 8.93% |
| 3 | Materials | 5.71% |
| 4 | Technology | 4.55% |
| 5 | Financials | 3.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Wells Fargo
WFC
$264B
| – | – |
-21,844
| Closed | -$1.2M |
|
102
Corpay
CPAY
$25.7B
| – | – |
-20,483
| Closed | -$3.05M |
|
|
ALXN
103
DELISTED
Alexion Pharmaceuticals
ALXN
| – | – |
-4,113
| Closed | -$761K |
|
|
MDCO
104
DELISTED
Medicines Co
MDCO
| – | – |
-21,327
| Closed | -$590K |
|
|
ESRX
105
DELISTED
Express Scripts Holding Company
ESRX
| – | – |
-16,154
| Closed | -$1.37M |
|
|
RLYP
106
DELISTED
RELYPSA INC COM
RLYP
| – | – |
-15,354
| Closed | -$473K |
|
|
RCPT
107
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| – | – |
-15,076
| Closed | -$1.85M |
|
|
INFA
108
DELISTED
INFORMATICA CORP
INFA
| – | – |
-31,727
| Closed | -$1.21M |
|
|
HOT
109
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
| – | – |
-30,387
| Closed | -$2.46M |
|
|
CELG
110
DELISTED
Celgene Corp
CELG
| – | – |
-25,941
| Closed | -$2.9M |
|
|
AGN
111
DELISTED
Allergan Inc
AGN
| – | – |
-34,684
| Closed | -$7.37M |
|
Similar funds
SWM
ACM
ECAU
SL
DII
FIM
EM
BHC
Partner Investment Management's Q1 2015 Portfolio in Review
As of Q1 2015, Partner Investment Management held 112 positions worth $66.4M, down 73% from $245M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Partner Investment Management withdrew a net $190M in Q1 2015, closing 30 positions and reducing 41 holdings. Its most notable exit was Microsoft, an estimated $18.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 52% of assets, up from 44% a quarter earlier, followed by Industrials and Materials.
Against the trend, Partner Investment Management opened a new position in Jazz Pharmaceuticals worth $1.7M.
- Partner Investment Management's largest Q1 2015 buy was Jazz Pharmaceuticals: 9,850 shares worth $1.7M.
- Partner Investment Management added most to Illumina in Q1 2015, an estimated $960K increase.
- Partner Investment Management's biggest Q1 2015 reduction was Vulcan Materials, cutting an estimated $21.4M.
- Partner Investment Management fully exited Microsoft in Q1 2015, selling an estimated $18.6M.
- Partner Investment Management's ten largest holdings make up 30% of its $66.4M portfolio in Q1 2015.
- Partner Investment Management opened 25 new positions and closed 30 in Q1 2015.
- Partner Investment Management's portfolio value fell 73% quarter-over-quarter to $66.4M.
Based on Partner Investment Management's 13F filing for Q1 2015, filed 15 May 2015.